Thomas Woiwode
Director, Avalanche Biotechnologies.
Companies
- Passage BIO, Inc.Board member Feb 27, 2020 to May 26, 20231
- Aligos Therapeutics, Inc.Board member Oct 15, 2020 to Jun 27, 20222
- Tempest Therapeutics, Inc.Board member Jun 29, 2021 to Jun 22, 20223
- Gritstone bio, Inc.Board member Sep 27, 2018 to Aug 27, 20214
- Avalanche BiotechnologiesBoard member May 20, 2016 to May 14, 20215
- CRISPR TherapeuticsBoard member Oct 18, 2016 to Jun 15, 20186
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Tempest Therapeutics, Inc. TPST7,377 shares7$4.7K at $0.63May 3, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Apr 29, 2022Bought 2,118,644 shares at $2.36 of Tempest Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARPassage BIO, Inc., Board member
- 2
- 3
- 4SEC EDGARGritstone bio, Inc., Board member
- 5
- 6SEC EDGARCRISPR Therapeutics, Board member
- 7